Co-Diagnostics Begins Clinical Testing for Respiratory Multiplex PCR Test
The company aims to support FDA 510(k) clearance submission for its point-of-care platform detecting flu A/B, COVID-19, and RSV.
The company aims to support FDA 510(k) clearance submission for its point-of-care platform detecting flu A/B, COVID-19, and RSV.
Research-use kit interrogates 84 genes using single-tube protocol, compatible with existing molecular laboratory equipment.
UCLA Health researchers find cell-free DNA combined with machine learning can distinguish ALS from other neurological conditions.
A simulation model shows that annual liquid biopsy screening would increase early-stage cancer detection by up to 30% while cutting stage IV diagnoses by 45%.
Researchers identify critical flaws in Oxford Nanopore devices that could expose or alter genetic data without detection.
Researchers urge clinicians to integrate lipid management into prenatal care to mitigate elevated obstetric complications and cardiovascular risks.
The gene expression test is designed to identify patients more likely to respond to JAK inhibitors versus Th2-targeted therapies.
The quantitative measurement test is designed to aid in myocardial infarction diagnosis using human plasma samples.
The validation enables its use as a blood-based biomarker for inclusion and exclusion in clinical trials in both the United States and Europe.
The automated system uses ion exchange HPLC technology to deliver A1c results while detecting common hemoglobin variants.
The agreement aims to improve early detection and management of chronic kidney disease in underserved populations through integrated diagnostics and digital health solutions.
The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.
TriVerity system demonstrated high sensitivity and specificity across more than 1,200 patients in pivotal SEPSIS-SHIELD trial.